We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.29B
AUM Growth
+$383M
Cap. Flow
+$337M
Cap. Flow %
10.23%
Top 10 Hldgs %
35.01%
Holding
141
New
13
Increased
43
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$38.1M
2
TMX
Terminix Global Holdings, Inc.
TMX
+$35.9M
3
EXAS
Exact Sciences
EXAS
+$35.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.8M
5
MYOV
Myovant Sciences Ltd.
MYOV
+$27.1M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$34.5M
2
ALTR
Altair Engineering Inc
ALTR
+$23.1M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$22.9M
4
OPLN
Openlane
OPLN
+$21.6M
5
QURE icon
uniQure
QURE
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 47.89%
2 Technology 19.59%
3 Industrials 8.32%
4 Consumer Discretionary 7.68%
5 Communication Services 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAA
51
DELISTED
IAA, Inc. Common Stock
IAA
$23.7M 0.72%
+610,000
New +$23.7M
APTV icon
52
Aptiv
APTV
$12B
$23.1M 0.7%
285,200
+10,200
+4% +$807K
STLD icon
53
Steel Dynamics
STLD
$36B
$22.8M 0.69%
754,000
– –
RARX
54
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$22.3M 0.68%
743,000
+383,100
+106% +$8.78M
LKFT
55
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$22.3M 0.68%
173,000
– –
KRTX
56
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$22.1M 0.67%
+1,136,234
New +$22.7M
INST
57
DELISTED
Instructure, Inc.
INST
$21.9M 0.67%
515,000
– –
ARGX icon
58
argenx
ARGX
$53.4B
$21.7M 0.66%
153,000
– –
QURE icon
59
uniQure
QURE
$3.03B
$20.3M 0.62%
260,000
-278,700
-52% -$17.8M
CRNX icon
60
Crinetics Pharmaceuticals
CRNX
$8.84B
$20.1M 0.61%
803,839
+419,839
+109% +$10.4M
HASI icon
61
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
$19.7M 0.6%
699,400
+6,400
+0.9% +$170K
PS
62
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$19.6M 0.59%
+645,000
New +$20.7M
AY
63
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$19.5M 0.59%
858,500
+1,500
+0.2% +$31.8K
PFPT
64
DELISTED
Proofpoint, Inc.
PFPT
$19M 0.58%
158,000
– –
BOLD
65
DELISTED
Audentes Therapeutics, Inc
BOLD
$18.9M 0.57%
499,000
– –
OKTA icon
66
Okta
OKTA
$24.7B
$18.5M 0.56%
150,000
– –
MNTA
67
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$15.4M 0.47%
1,236,000
-797,144
-39% -$10.6M
OPLN
68
Openlane
OPLN
$4.21B
$15.3M 0.46%
610,000
-1,001,620
-62% -$21.6M
TECX
69
Tectonic Therapeutic
TECX
$529M
$15.1M 0.46%
77,408
– –
RCKT icon
70
Rocket Pharmaceuticals
RCKT
$340M
$14.9M 0.45%
994,314
+285,714
+40% +$4.99M
RGEN icon
71
Repligen
RGEN
$7.96B
$14.5M 0.44%
169,000
+59,000
+54% +$4.02M
STKL
72
DELISTED
SunOpta
STKL
$14.1M 0.43%
4,300,540
– –
STRO icon
73
Sutro Biopharma
STRO
$401M
$13.8M 0.42%
124,490
– –
IMMU
74
DELISTED
Immunomedics Inc
IMMU
$13.4M 0.41%
966,000
-446,000
-32% -$6.71M
ISRG icon
75
Intuitive Surgical
ISRG
$127B
$13.1M 0.4%
+75,000
New +$12.9M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Eventide Asset Management held 141 positions worth $3.29B, up 13% from $2.91B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Eventide Asset Management deployed $337M of net new capital in Q2 2019, opening 13 new positions and adding to 43 existing holdings. Its largest new stake was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was bluebird bio, an estimated $34.5M trimmed.

  • Eventide Asset Management's largest Q2 2019 buy was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q2 2019, an estimated $38.1M increase.
  • Eventide Asset Management's biggest Q2 2019 reduction was bluebird bio, cutting an estimated $34.5M.
  • Eventide Asset Management fully exited Altair Engineering Inc in Q2 2019, selling an estimated $23.1M.
  • Eventide Asset Management's ten largest holdings make up 35% of its $3.29B portfolio in Q2 2019.
  • Eventide Asset Management opened 13 new positions and closed 25 in Q2 2019.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $3.29B.

Based on Eventide Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.